1. 121. Consistent long term efficacy and safety of repeat onabotulinumtoxinA injections in patients with neurogenic detrusor overactivity: final results of up to 4 years' treatment. (January 2015) Authors: Kennelly, Michael; Dmochowski, Roger; Ethans, Karen; Moore, Courtenay; Schulte-Baukloh, Heinrich; Jenkins, Brenda; Guard, Steven; Zheng, Yan; Karsenty, Gilles Journal: Toxicon Issue: Volume 93(2015)Supplement Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long‐term extension study. Issue 2 (24th November 2015) Authors: Kennelly, Michael; Dmochowski, Roger; Schulte‐Baukloh, Heinrich; Ethans, Karen; Del Popolo, Giulio; Moore, Courtenay; Jenkins, Brenda; Guard, Steven; Zheng, Yan; Karsenty, Gilles Journal: Neurourology and urodynamics Issue: Volume 36:Issue 2(2017:Feb.) Page Start: 368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In vitro behavior and UV response of melanocytes derived from carriers of CDKN2A mutations and MC1R variants. (5th September 2018) Authors: Hernando, Barbara; Swope, Viki B.; Guard, Steven; Starner, Renny J.; Choi, Kevin; Anwar, Ayesha; Cassidy, Pamela; Leachman, Sancy; Kadekaro, Ana Luisa; Bennett, Dorothy C.; Abdel‐Malek, Zalfa A. Journal: Pigment cell & melanoma research Issue: Volume 32:Number 2(2019) Page Start: 259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗